Liminal BioSciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Liminal BioSciences's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 38% to $401,000. The net income raised on -$28,916,000 and profit margin reached -7211%. Total operating expenses were $33,164,000.
Profit Margin
| 2013 | 20.64M | -16.48M | -79.87% |
|---|---|---|---|
| 2014 | 23.01M | 5.93M | 25.81% |
| 2015 | 24.53M | -50.96M | -207.72% |
| 2016 | 16.39M | -100.80M | -614.98% |
| 2017 | 39.11M | -109.73M | -280.53% |
| 2018 | 47.37M | -195.36M | -412.39% |
| 2019 | 4.90M | -234.22M | -4776.18% |
| 2020 | 3.31M | -122.13M | -3682.15% |
| 2021 | 643K | -45.06M | -7008.24% |
| 2022 | 401K | -28.91M | -7210.97% |
LMNL Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 401K | 643K | 3.31M | 4.90M | 47.37M | 39.11M | 16.39M | 24.53M | 23.01M | 20.64M |
Cost of revenue | 0 | 0 | 2.03M | 2.76M | 38.00M | 10.14M | 6.75M | 8.21M | 7.01M | 6.59M |
Gross profit | 401K | 643K | 1.28M | 2.14M | 9.37M | 28.96M | 9.63M | 16.31M | 15.99M | 14.05M |
Operating exp. | ||||||||||
Research and development | 15.29M | 18.34M | 56.82M | 75.11M | 91.66M | 100.39M | 88.07M | 50.25M | 35.2M | 18.56M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 33.16M | 50.27M | 95.37M | 120.39M | 123.19M | 152.32M | 117.37M | 66.82M | 48.10M | 27.14M |
Operating income | -32.97M | -49.55M | -94.27M | -210.63M | -113.54M | -123.04M | -107.38M | -50.13M | 2.57M | -10.10M |
Other income (expenses), net | 3.53M | 4.61M | -28.06M | -23.83M | -122.02M | -11.74M | -4.61M | -11.41M | 31.63M | -2.37M |
Income before tax | -29.44M | -44.94M | -122.33M | -234.46M | -257.91M | -134.78M | -116.88M | -61.92M | -480K | -17.26M |
Income tax expense | -525K | 118K | -201K | -237K | -20.01M | -14.75M | -6.21M | -5.13M | -3.05M | 131K |
Net income | -28.91M | -45.06M | -122.13M | -234.22M | -195.36M | -109.73M | -100.80M | -50.96M | 5.93M | -16.48M |
Earnings per share | ||||||||||
Basic EPS | -9.32 | -14.94 | -49.97 | -145.82 | -2.35K | -1.37K | -1.68K | -892.74 | 100 | -339.91 |
Diluted EPS | -9.32 | -14.94 | -49.97 | -145.82 | -2.35K | -1.37K | -1.68K | -892.74 | 100 | -339.91 |
| Data source | Data source | Data source | Data source |